The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma
Kevin C. Miller(Memorial Sloan Kettering Cancer Center), Shaji Kumar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Prashant Kapoor, Wilson I. Gonsalves(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), William J. Hogan(Mayo Clinic), Angela A. Dispenzieri(Mayo Clinic in Arizona), David Dingli, Suzanne R. Hayman, Francis K. Buadi
Cited by 13
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k